ANNA-MAIJA TOLPPANEN

Contact info

Keywords

Research groups

• MEDALZ

Publications

• Hakala Anna; Tolppanen, Anna-Maija; Koponen, Marjaana; Taipale, Heidi; Tanskanen, Antti; Hartikainen, Sirpa; Tiihonen, Miia. 2021. Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease? Journal of the american medical directors association [In Press, Corrected Proof]: [In Press, Corrected Proof]. 2021
• Kuusimäki, Tomi; Al¿Abdulrasul, Haidar; Kurki, Samu; Hietala, Jarmo; Hartikainen, Sirpa; Koponen, Marjaana; Tolppanen, Anna¿Maija; Kaasinen, Valtteri. 2021. Increased Risk of Parkinson's Disease in Patients With Schizophrenia Spectrum Disorders Movement disorders [Epub ahead of print 6 Jan 2021]: 1-10. 2021
• Paakinaho, Anne; Karttunen, Niina; Koponen, Marjaana; Taipale, Heidi; Tolppanen, Anna-Maija; Hartikainen, Sirpa; Tiihonen, Miia. 2020. Incidence of muscle relaxant use in relation to diagnosis of Parkinson's disease International journal of clinical pharmacy 42: 336-340. 2020
• Wihersaari, Olga; Karjalainen, Päivi; Tolppanen, Anna-Maija; Mattsson, Nina; Jalkanen, Jyrki; Nieminen, Kari. 2020. Complications of Pelvic Organ Prolapse Surgery in the 2015 Finnish Pelvic Organ Prolapse Surgery Survey Study Obstetrics and gynecology 136 6: 1135-1144. 2020
• Vu, Mai; Koponen, Marjaana; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Kettunen, Raimo; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease International journal of cardiology 300: 221-225. 2020
• Tolppanen, Anna-Maija; Taipale, Heidi; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa. 2020. Causes of death in a nationwide cohort of community-dwellers with Alzheimer's disease Bmc geriatrics 20 1: 441. 2020
• Tapiainen, V; Lavikainen, P; Koponen, M; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM. 2020. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease Journal of the american geriatrics society 68 3: 595-602. 2020
• Sluggett, JK; Koponen, M; Bell, JS; Taipale, H; Tanskanen, A; Tiihonen, J; Uusitupa, M; Tolppanen, AM; Hartikainen, S. 2020. Metformin and risk of Alzheimer's disease among community-dwelling people with diabetes: a national case-control study Journal of clinical endocrinology and metabolism 105 4: dgz234. 2020
• Sarycheva, Tatyana; Lavikainen, Piia; Taipale, Heidi; Tiihonen, Jari; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease Neurology 94 20: e2099-e2108. 2020
• Rysä, Jaana; Lehtonen, Elise; Tolppanen, Anna-Maija; Hukkanen, Janne. 2020. Tiatsididiureettien käyttö suurentaa luuntiheyttä ja pienentää murtumariskiä - järjestelmällinen kirjallisuuskatsaus ja meta-analyysi Dosis 36 2: 180-195. 2020
• Rajamaki, Blair; Koponen, Marjaana; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Length of hospital stay after hip fracture and readmission rates of persons with and without Alzheimer's disease: a matched cohort study Bmc geriatrics 20 1: 214. 2020
• Rajamäki, Blair; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Psychotropic Drug-Associated Pneumonia in Older Adults Drugs and aging 37: 241-261. 2020
• Neuvonen, Elisa; Hall, Anette; Tolppanen, Anna-Maija; Ngandu, Tiia; Rusanen, Minna; Laatikainen, Tiina; Soininen, Hilkka; Kivipelto, Miia; Solomon, Alina. 2020. Late-life personality traits, cognitive impairment, and mortality in a population-based cohort International journal of geriatric psychiatry 35 9: 989-999. 2020
• Karjalainen, Päivi K; Mattsson, Nina K: Jalkanen, Jyrki T; Nieminen, Kari; Tolppanen, Anna-Maija. 2020. Minimal important difference and patient acceptable symptom state for PFDI-20 and POPDI-6 in POP surgery International urogynecology journal [Published: 02 September 2020]: 1-8. 2020
• Anttila, Margareta; Hartikainen, Sirpa; Herukka, Sanna-Kaisa; Kaasinen, Valtteri; Tolppanen, Anna-Maija. 2020. Parkinsonin taudin lääkkeiden erityiskorvausoikeuden saajien määrän muutos vuosina 1996-2015 Lääkärilehti 75 43-44: 2297-2303. 2020
• Braithwaite, B; Paananen, J; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, A-M. 2020. Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory International journal of medical informatics 141: 104142. 2020
• Mattsson, NK; Karjalainen, P; Tolppanen, AM; Heikkinen, AM; Sintonen, H; Härkki, P; Nieminen, K; Jalkanen, J. 2020. Pelvic organ prolapse surgery and quality of life - a nationwide cohort study American journal of obstetrics and gynecology 222 6: 588.e1-588.e10. 2020
• Ilomäki, J; Bell, JS; Chan, AYL; Tolppanen, AM; Luo, H; Wei, L; Lai, EC; Shin, JY; De Paoli, G; Pajouheshnia, R; Ho, FK; Reynolds, L; Lau, KK; Crystal, S; Lau, WCY; Man, KKC; Brauer, R; Chan, EW; Shen, CY; Kim, JH; et al. incl. Hartikainen, S; Koponen, M. 2020. Application of Healthcare 'Big Data' in CNS Drug Research: The Example of the Neurological and Mental Health Global Epidemiology Network (NeuroGEN) Cns drugs Published: 22 June 2020: 1-7. 2020
• Lampela, P; Tolppanen, AM; Koponen, M; Tanskanen, A; Tiihonen, J; Hartikainen, S; Taipale, H. 2020. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease Journal of Alzheimer's disease 73 3: 1243-1251. 2020
• Lavikainen, Piia; Koponen, Marjaana; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2020. Length of hospital stay for hip fracture and 30-day mortality in people with Alzheimer's disease: a cohort study in Finland Journals of gerontology series a: biological sciences and medical sciences 75 11: 2184-2192. 2020
• Liehu, Maija; Tiihonen, Miia; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Tolppanen, Anna-Maija; Hartikainen, Sirpa; Koponen, Marjaana. 2020. Psykoosilääkkeiden käyttö on pitkäkestoista Alzheimerin tautia sairastavilla Dosis 36 1: 6-23. 2020
• Mattsson, Nina K; Karjalainen, Päivi; Heikkinen, Anna-Mari; Nieminen, Kari; Jalkanen, Jyrki; Tolppanen, Anna-Maija. 2020. Agreement between patient global impression scale of improvement, pelvic floor distress inventory and 15D in measuring the outcome of pelvic organ prolapse surgery Neurourology and urodynamics 39 8: 2171-2178. 2020
• Lavikainen, Piia; Taipale, Heidi; Tanskanen, Antti; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2019. Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease Journal of the american medical directors association 20 6: 751-758. 2019
• Taipale, H; Rysä, J; Hukkanen, J; Koponen, M; Tanskanen, A; Tiihonen, J; Kröger, H; Hartikainen, S; Tolppanen, AM. 2019. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study Osteoporosis international 30 7: 1481-1489. 2019
• Taipale, H; Lampela, P; Koponen, M; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM. 2019. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study Journal of Alzheimer's disease 68 1: 127-136. 2019
• Pölönen, Satu; Tiihonen, Miia; Nykänen, Irma; Taipale, Heidi; Tolppanen, Anna-Maija; Hartikainen, Sirpa. 2019. Incidence of prescription vitamin B12 use in relation to diagnosis of Alzheimer's disease among community-dwelling persons Journal of public health 27 6: 775-779. 2019
• Methodological Challenges in Epidemiological Studies. Ilomäki, Jenni; Tolppanen, Anna-Maija / Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Volume 2. 2019. 2019
• Mattsson, NK; Karjalainen, P; Tolppanen, AM; Heikkinen, AM; Jalkanen, J; Härkki, P; Nieminen K. 2019. Methods of surgery for pelvic organ prolapse in a nationwide Cohort (FINPOP 2015) Acta obstetricia et gynecologica scandinavica 98 4: 451-459. 2019
• Lintula, E; Tiihonen, M; Taipale, H; Tolppanen, AM; Tanskanen, A; Tiihonen, J; Hartikainen, S; Hamina, A. 2019. Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease Drugs and aging 2020; 37: 193-203. 2019
• Cui, LL; Golubczyk, D; Tolppanen, AM; Boltze, J; Jolkkonen, J. 2019. Cell therapy for ischemic stroke: are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Annals of neurology 86 1: 5-16. 2019
• Koponen, Marjaana; Lavikainen, Piia; Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2019. Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease Journal of the american medical directors association 20 12: 1488-1494.e3. 2019
• Karjalainen, PK; Mattsson, NK; Nieminen, K; Tolppanen, AM; Jalkanen, JT. 2019. The relationship of defecation symptoms and posterior vaginal wall prolapse in women undergoing pelvic organ prolapse surgery American journal of obstetrics and gynecology 221 5: 480.e1-480.e10. 2019
• Kalamägi, J; Lavikainen, P; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM. 2019. Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease Annals of medicine 51 5-6: 294-305. 2019
• Juhola, Laura; Taipale, Heidi; Koponen, Marjaana; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2019. Alzheimer-potilaat ja psyykenlääkkeiden käyttö 2005-2011 Lääkärilehti 74 10: 609-616. 2019
• Ilmaniemi, S; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, AM. 2019. Incidence of head injury and traumatic brain injury among people with Alzheimer's disease Journal of epidemiology and community health 73 5: 451-454. 2019
• Heiskanen, J; Hartikainen, J; Martikainen, J; Miettinen, H; Hippeläinen, M; Roine, RP; Tolppanen, AM. 2019. Purchases of medical therapy recommended for coronary artery disease before and after elective revascularisation European journal of clinical pharmacology 2020; 76: 81-88. 2019
• Hamina, A; Taipale, H; Karttunen, N; Tanskanen, A; Tiihonen, J; Tolppanen, AM; Hartikainen, S. 2019. Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease Journal of Alzheimer's disease 69 3: 807-816. 2019
• Taipale, H; Gomm, W; Broich, K; Maier, W; Tolppanen, AM; Tanskanen, A; Tiihonen, J; Hartikainen, S; Haenisch, B. 2018. Use of antiepileptic drugs and dementia risk - an analysis of Finnish health register and German health insurance data JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 66 6: 1123-1129. 2018
• Torvinen-Kiiskinen, S; Tolppanen, AM; Koponen, M; Tanskanen, A; Tiihonen, J; Hartikainen, S; Taipale, H. 2018. Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease - a nested case-control study. ALIMENTARY PHARMACOLOGY AND THERAPEUTICS 47 8: 1135-1142. 2018
• Torvinen-Kiiskinen, S; Tolppanen, AM; Koponen, M; Tanskanen, A; Tiihonen, J; Hartikainen, S; Taipale, H. 2018. Editorial: let's take a break from studying the PPI-fracture association - Authors' reply Alimentary pharmacology and therapeutics 47 11: 1544-1545. 2018
• Tolppanen, Anna-Maija; Tiihonen, Miia; Taipale, Heidi; Koponen, Marjaana; Tanskanen, Antti; Lavikainen, Piia; Tiihonen, Jari; Hartikainen, Sirpa. 2018. Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study DRUGS & AGING 35 11: 985-992. 2018
• Tapiainen, V; Taipale, H; Tanskanen, A; Tiihonen, J; Hartikainen, S; Tolppanen, A-M. 2018. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study ACTA PSYCHIATRICA SCANDINAVICA 138 2: 91-100. 2018
• Taipale, Heidi; Hamina, Aleksi; Karttunen, Niina; Koponen, Marjaana; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2018. Incident opioid use and risk of hip fracture among persons with Alzheimer's disease, a nationwide matched cohort study Pain 2019; 160 2: 417-423. 2018
• Orsel, Kim; Taipale, Heidi; Tolppanen, Anna-Maija; Koponen, Marjaana; Tanskanen, Antti; Tiihonen, Jari; Gardarsdottir, Helga; Hartikainen, Sirpa. 2018. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease EUROPEAN NEUROPSYCHOPHARMACOLOGY 28 11: 1260-1269. 2018
• Sund, Reijo; Tolppanen, Anna-Maija. 2018. Kansalliset rekisteritiedot lääke-epidemiologisen tutkimuksen perustana Sic! Lääketietoa Fimeasta 8 2: 25-26. 2018
• Kettunen, Reetta; Taipale, Heidi; Tolppanen, Anna-Maija; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa; Koponen, Marjaana. 2018. Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease European journal of clinical pharmacology 2019; 75 3: 417-425. 2018
• Järvinen, Heli; Taipale, Heidi; Koponen, Marjaana; Tanskanen, Antti; Tiihonen, Jari; Tolppanen, Anna-Maija; Hartikainen, Sirpa. 2018. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study Journal of Alzheimer's disease 64 2: 437-445. 2018
• Karttunen, Niina; Taipale, Heidi; Hamina, Aleksi; Tanskanen, Antti; Tiihonen, Jari; Tolppanen, Anna-Maija; Hartikainen, Sirpa. 2018. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease - A nationwide register-based study in Finland International journal of geriatric psychiatry 2019; 34 2: 280-288. 2018
• Sarycheva, Tatyana; Taipale, Heidi; Lavikainen, Piia; Tiihonen, Jari; Tanskanen, Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2018. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease Journal of Alzheimer's Disease 66 1: 387-395. 2018
• Orsel, Kim; Taipale, Heidi; Raatikainen, Sami; Lampela, Pasi; Tolppanen, Anna-Maija; Koponen, Marjaana; Tanskanen, Antti; Tiihonen, Jari; Gardarsdottir, Helga; Hartikainen, Sirpa. 2018. Antipsychotic Use and the Risk of Initiating Medication for Benign Prostate Hyperplasia in Persons With Alzheimer Disease: A Matched Cohort Study JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 38 5: 494-497. 2018
• Hamina, Aleksi; Lavikainen, Piia; Tanskanen, Antti; Tolppanen, Anna-Maija; Tiihonen, Jari; Hartikainen, Sirpa; Taipale, Heidi. 2018. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease INTERNATIONAL PSYCHOGERIATRICS 30 7: 947-956. 2018
• Sarycheva, Tatyana; Lavikainen, Piia; Taipale, Heidi; Tiihonen, Jari; Tanskanen; Antti; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2018. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study Journal of the American Heart Association 7 18: e009742. 2018
• Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Tolppanen Anna-Maija. 2017. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study. Alzheimer's Research & Therapy 9 1: 59. 2017
• Tolppanen Anna-Maija, Taipale Heidi, Hartikainen Sirpa. 2017. Head or brain injuries and Alzheimer's disease : a nested case-control register study. Alzheimer's & Dementia 13 12: 1371-1379. 2017
• Tolppanen A-M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Paananen J, Tiihonen J, Hartikainen S. 2017. Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26 8: 875-889. 2017
• Tolppanen A-M, Voutilainen A, Taipale H, Tanskanen A, Lavikainen P, Koponen M, Tiihonen J, Hartikainen S. 2017. Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011. PLOS ONE 12 3: e0173450. 2017
• Tapiainen V, Hartikainen S, Taipale H, Tiihonen J, Tolppanen A-M. 2017. Hospital-treated mental and behavioral disorders and risk of Alzheimer's disease: A nationwide nested case-control study. EUROPEAN PSYCHIATRY: THE JOURNAL OF THE ASSOCIATION OF EUROPEAN PSYCHIATRISTS 43: 92-98. 2017
• Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. 2017. Drug exposure in register-based research - An expert-opinion based evaluation of methods. PLOS ONE 12 9: e0184070. 2017
• Taipale Heidi, Tolppanen Anna-Maija, Tiihonen Miia, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa. 2017. No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease. AMERICAN JOURNAL OF GASTROENTEROLOGY 112: 1802-1808. 2017
• Taipale Heidi, Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa. 2017. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling persons with Alzheimer's disease. CANADIAN MEDICAL ASSOCIATION JOURNAL 189 14: E519-E529. 2017
• Torvinen-Kiiskinen Sanna, Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2017. Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY 32 12: e107-e115. 2017
• Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Tolppanen Anna-Maija, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa. 2017. Use of benzodiazepines and related drugs is associated with risk of stroke among persons with Alzheimer's disease. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY 32 3: 135-141. 2017
• Taipale H, Hamina A, Lampela P, Tanskanen A, Tiihonen J, Karttunen N, Tolppanen AM, Hartikainen S. 2017. Is Alzheimer's Disease Associated with Previous Opioid Use? Pain medicine 2018; 19 11: 2115-2121. 2017
• Oinasmaa S, Heiskanen J, Hartikainen J, Hippeläinen M, Miettinen H, Martikainen J, Roine RP, Tolppanen AM. 2017. Does routinely collected patient-reported outcome data represent the actual case-mix of elective coronary revascularization patients? European Heart Journal - Quality of Care and Clinical Outcomes 2018; 4 2: 113-119. 2017
• Mattsson NK, Nieminen K, Heikkinen A-M, Jalkanen J, Koivurova S, Eloranta M-L, Suvitie P, Tolppanen A-M. 2017. Validation of the short forms of the Pelvic Floor Distress Inventory (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7), and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) in Finnish. HEALTH AND QUALITY OF LIFE OUTCOMES [ONLINE] 15 1: 88. 2017
• Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S. 2017. Antipsychotic use and the risk of hip fracture among community-dwelling persons with Alzheimer's disease. JOURNAL OF CLINICAL PSYCHIATRY 78 3: e257-e263. 2017
• Juntunen Heidi, Taipale Heidi, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa, Tiihonen Miia. 2017. Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 73 9: 1149-1158. 2017
• Imtiaz B, Tuppurainen M, Rikkonen T, Kivipelto M, Soininen H, Kröger H, Tolppanen A-M. 2017. Postmenopausal hormone therapy and Alzheimer disease. A prospective cohort study. NEUROLOGY 88 11: 1062-1068. 2017
• Imtiaz B, Taipale H, Tanskanen A, Tiihonen M, Kivipelto M, Heikkinen A-M, Tiihonen J, Soininen H, Hartikainen S, Tolppanen A-M. 2017. Risk of Alzheimer's disease among users of postmenopausal hormonetherapy: A nationwide case-control study. MATURITAS 98: 7-13. 2017
• Hyttinen V, Taipale H, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Valtonen H. 2017. Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease. ANNALS OF PHARMACOTHERAPY 51 9: 725-734. 2017
• Heiskanen J, Tolppanen A-M, Martikainen J, Hartikainen J, Miettinen H, Hippeläinen M, Roine RP. 2017. Targeted identification of adverse events in coronary artery disease patients based on patient-reported outcomes. Journal of Comparative Effectiveness Research 6 7: 583-589. 2017
• Saarelainen Laura, Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2017. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY 2018; 33 4: 583-590. 2017
• Tiihonen Miia, Taipale Heidi, Tolppanen Anna-Maija, Hartikainen Sirpa. 2016. Incidence of Bisphosphonate Use in Relation to Diagnosis of Alzheimer's Disease in Community-Dwelling Persons. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 64 9: e48 - e49. 2016
• Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2016. Drug use in persons with and without Alzheimer's disease aged 90 years or more. AGE AND AGEING 45 6: 900-904. 2016
• Taipale Heidi, Tanskanen Antti, Koponen Marjaana, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2016. Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons. Clinical Epidemiology 8: 363-371. 2016
• Taipale Heidi, Tolppanen Anna-Maija, Purhonen Maija, Tanskanen Antti, Ahonen Riitta, Tiihonen Jari, Hartikainen Sirpa. 2016. Alueelliset erot sairaalapäivissä ja lääkekustannuksissa Alzheimerin tautia sairastavilla ja verrokeilla [English Summary: Regional differences in number of hospital days and drug costs in people with and without Alzheimer's disease]. SUOMEN LÄÄKÄRILEHTI 71 22: 1613-1619a. 2016
• Puranen Arto, Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2016. Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY 2017; 32 1: 94-101. 2016
• Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2016. Antipsychotic use and risk of hospitalization or death due to pneumonia in persons with and without Alzheimer's disease. CHEST 150 6: 1233-1241. 2016
• Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2016. Psykoosilääkkeet yhteydessä Alzheimer-potilaiden keuhkokuumeriskiin. DUODECIM 132 16: 1490. 2016
• Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana, Lavikainen Piia, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa. 2016. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study. BMJ Open 6 7: e012100. 2016
• Tolppanen Anna-Maija, Taipale Heidi, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa. 2016. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study. BMC GERIATRICS [ONLINE: HTTP://WWW.BIOMEDCENTRAL.COM/BMCGERIATR/] 16 1: 204. 2016
• Saarelainen Laura, Tolppanen Anna-Maija, Koponen Marjaana, Tanskanen Antti, Sund Reijo, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2016. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease. Journal of the American Medical Directors Association 2017; 18 1: 87.e15-87.e21. 2016
• Hamina Aleksi, Taipale Heidi, Tanskanen Antti, Tolppanen Anna-Maija, Karttunen Niina, Pylkkänen Liisa, Tiihonen Jari, Hartikainen Sirpa. 2016. Long-term use of opioids for non-malignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study. PAIN 2017; 158 2: 252-260. 2016
• Moga Daniela C, Taipale Heidi, Tolppanen Anna-Maija, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa, Wu Qishan, Jicha Gregory A, Gnjidic Danijela. 2016. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland. DRUGS & AGING 2017; 34 1: 55-65. 2016
• Lampela Pasi, Tolppanen Anna-Maija, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa, Taipale Heidi. 2016. Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study. Journal of Alzheimer's Disease 2017; 56 1: 119-128. 2016
• Koponen Marjaana, Taipale Heidi, Lavikainen Piia, Tanskanen Antti, Tiihonen Jari, Tolppanen Anna-Maija, Ahonen Riitta, Hartikainen Sirpa. 2016. Risk of Mortality associated with Antipsychotic Monotherapy and Polypharmacy among Community-Dwelling Persons with Alzheimer's Disease. Journal of Alzheimer's Disease 2017; 56 1: 107-118. 2016
• Imtiaz Bushra, Tolppanen Anna-Maija, Solomon Alina, Soininen Hilkka, Kivipelto Miia. 2016. Estradiol and Cognition in the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Cohort Study. Journal of Alzheimer's Disease 2017; 56 2: 453-458. 2016
• Hyttinen Virva, Taipale Heidi, Tanskanen Antti, Tiihonen Jari, Tolppanen Anna-Maija, Hartikainen Sirpa, Valtonen Hannu. 2016. Risk Factors for Initiation of Potentially Inappropriate Medications in Community-Dwelling Older Adults with and without Alzheimer's Disease. DRUGS & AGING 2017; 34 1: 67-77. 2016
• Heiskanen Jari, Tolppanen Anna-Maija, Roine Risto P, Hartikainen Juha, Hippeläinen Mikko, Miettinen Heikki, Martikainen Janne. 2016. Comparison of EQ-5D and 15D instruments for assessing the health-related quality of life in cardiac surgery patients. European Heart Journal - Quality of Care and Clinical Outcomes 2 3: 193-200. 2016
• Heiskanen Jari, Martikainen Janne, Miettinen Heikki, Hippeläinen Mikko, Roine Risto P, Hartikainen Juha, Tolppanen Anna-Maija. 2016. The coverage of elective revascularisation procedure codes in the National Finnish Hospital Discharge Register. Annals of Medicine 48 7: 552-558. 2016
• Heiskanen Jari, Hartikainen Sirpa, Taipale Heidi, Tolppanen Anna-Maija. 2016. Muistisairauksista aiheutuva erikoissairaanhoito ennen Alzheimerin taudin lääkekorvausoikeutta [English summary: Periods of hospital treatment and hospital visits before entitlement to special reimbursement for antidemetia medication]. SUOMEN LÄÄKÄRILEHTI 71 22: 1607-1611a. 2016
• Hartikainen Sirpa, Paananen Jussi, Taipale Heidi, Tanskanen Antti, Tiihonen Jari, Tolppanen Anna-Maija. 2016. Dementialääkkeitä käytetään esitettyä pidempään [Ajassa | keskustelua]. SUOMEN LÄÄKÄRILEHTI 71 47: 3003. 2016
• Hamina Aleksi, Taipale Heidi, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2016. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease. EUROPEAN JOURNAL OF PAIN (LONDON) 2017; 21 4: 658-667. 2016
• Lampela Pasi, Tolppanen Anna-Maija, Tanskanen Antti, Tiihonen Jari, Lavikainen Piia, Hartikainen Sirpa, Taipale Heidi. 2016. Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease. Annals of Medicine 2017; 49 3: 230-239. 2016
• Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2015. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY 30 4: 202-208. 2015
• Voutilainen Ari, Hartikainen Sirpa, Sherwood Paula R, Taipale Heidi, Tolppanen Anna-Maija, Vehviläinen-Julkunen Katri. 2015. Associations across spatial patterns of disease incidences, socio-demographics, and land use in Finland 1991-2010. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH 43 4: 356-363. 2015
• Tanskanen Antti, Taipale Heidi, Koponen Marjaana, Tolppanen Anna-Maija, Hartikainen Sirpa, Ahonen Riitta, Tiihonen Jari. 2015. From prescription drug purchases to drug use periods - a second generation method (PRE2DUP). BMC MEDICAL INFORMATICS AND DECISION MAKING 15: 21. 2015
• Taipale Heidi, Purhonen Maija, Tolppanen Anna-Maija, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa. 2015. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH 44(2016): 150-158. 2015
• Heiskanen Jari, Hartikainen Sirpa, Roine Risto P, Tolppanen Anna-Maija. 2015. 30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer's Disease. Journal of Alzheimer's Disease 48 1: 241-249. 2015
• Saarelainen Laura, Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2015. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease. Journal of Alzheimer's Disease 2016; 49 3: 809-818. 2015
• Koponen Marjaana, Tolppanen Anna-Maija, Taipale Heidi, Tanskanen Antti, Tiihonen Jari, Johnell Kristina, Fastbom Johan, Ahonen Riitta, Hartikainen Sirpa. 2015. Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons. BRITISH JOURNAL OF PSYCHIATRY 207: 444-449. 2015
• Koponen Marjaana, Taipale Heidi, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Ahonen Riitta, Hartikainen Sirpa. 2015. Long-term use of antipsychotics among community-dwelling persons with Alzheimer's disease: A nationwide register-based study. EUROPEAN NEUROPSYCHOPHARMACOLOGY 25 10: 1706-1713. 2015
• Aartolahti Eeva, Tolppanen Anna-Maija, Lönnroos Eija, Hartikainen Sirpa, Häkkinen Arja. 2015. Health condition and physical function as predictors of adherence in long-term strength and balance training among community-dwelling older adults. ARCHIVES OF GERONTOLOGY AND GERIATRICS (LIMERICK) 61 3: 452-457. 2015
• Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2014. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort. EUROPEAN NEUROPSYCHOPHARMACOLOGY 24: 1729-1737. 2014
• Voutilainen Ari, Tolppanen Anna-Maija, Vehviläinen-Julkunen Katri, Sherwood Paula R.. 2014. From spatial ecology to spatial epidemiology: modeling spatial distributions of different cancer types with principal coordinates of neighbor matrices. Emerging Themes in Epidemiology 11: 11. 2014
• Tolppanen Anna-Maija, Taipale Heidi, Purmonen Timo, Koponen Marjaana, Soininen Hilkka, Hartikainen Sirpa. 2014. Hospital admissions, outpatient visits and healthcare costs of community-dwellers with Alzheimer's disease. Alzheimer's & Dementia 2015; 11 8: 955-963. 2014
• Tanskanen Antti, Taipale Heidi, Koponen Marjaana, Tolppanen Anna-Maija, Hartikainen Sirpa, Ahonen Riitta, Tiihonen Jari. 2014. From prescriptions to drug use periods - things to notice. BMC RESEARCH NOTES (ONLINE) 7: 796. 2014
• Taipale Heidi, Tanskanen Antti, Koponen Marjaana, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2014. Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY 29: 216-223. 2014
• Tolppanen Anna-Maija, Solomon Alina, Kulmala Jenni, Kåreholt Ingemar, Ngandu Tiia, Rusanen Minna, Laatikainen Tiina, Soininen Hilkka, Kivipelto Miia. 2014. Leisure-time physical activity from mid- to late life, body mass index, and risk of dementia. Alzheimer's & Dementia Epub ahead of print: -. 2014
• Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2014. Antipsychotic Polypharmacy among a Nationwide Sample of Community-Dwelling Persons with Alzheimer's Disease. Journal of Alzheimer's Disease 41: 1223-1228. 2014
• Neuvonen Elisa, Rusanen Minna, Solomon Alina, Ngandu Tiia, Laatikainen Tiina, Soininen Hilkka, Kivipelto Miia, Tolppanen Anna-Maija. 2014. Late-life cynical distrust, risk of incident dementia, and mortality in a population-based cohort. NEUROLOGY 82: 2205-2212. 2014
• Imtiaz Bushra, Tuppurainen Marjo, Tiihonen Miia, Kivipelto Miia, Soininen Hilkka, Hartikainen Sirpa, Tolppanen Anna-Maija. 2014. Oophorectomy, Hysterectomy, and Risk of Alzheimer's Disease: A Nationwide Case-Control Study. Journal of Alzheimer's Disease 42: 575-581. 2014
• Imtiaz Bushra, Tolppanen Anna-Maija, Kivipelto Miia, Soininen Hilkka. 2014. Future directions in Alzheimer's disease from risk factors to prevention. BIOCHEMICAL PHARMACOLOGY 88: 661-670. 2014
• Hartikainen Sirpa, Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana. 2014. MEDALZ -Medication use and Alzheimer's disease. DOSIS : FARMASEUTTINEN AIKAKAUSKIRJA 30 3: 234. 2014
• Gnjidic Danijela, Hilmer Sarah N, Hartikainen Sirpa, Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana, Bell J. Simon. 2014. Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer's disease: a national population cohort study. PLOS ONE [ONLINE] 9 1: e83224. 2014
• Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Tolppanen Anna-Maija, Tiihonen Jari, Hartikainen Sirpa. 2014. Antipsychotic Doses Among Community-Dwelling Persons With Alzheimer Disease in Finland. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 34: 435-440. 2014
• Tolppanen Anna-Maija, Lavikainen Piia, Solomon Alina, Kivipelto Miia, Uusitupa Matti, Soininen Hilkka, Hartikainen Sirpa. 2013. History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study. DIABETES CARE 36: 2015-2019. 2013
• Tolppanen Anna-Maija. 2013. Prediction of dementia in people with diabetes. The Lancet Diabetes & Endocrinology 1: 164-165. 2013
• Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana, Lavikainen Piia, Tanskanen Antti, Tiihonen Jari, Hartikainen Sirpa. 2013. Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study. Clinical Epidemiology 5: 277-285. 2013
• Tolppanen A-M, Ngandu T, Kåreholt I, Laatikainen T, Rusanen M, Soininen H, Kivipelto M. 2013. Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. Journal of Alzheimer's Disease online 2014;38(1):201-9: -. 2013
• Tolppanen Anna-Maija, Lavikainen Piia, Solomon Alina, Kivipelto Miia, Soininen Hilkka, Hartikainen Sirpa. 2013. Incidence of stroke in people with Alzheimer disease. A national register-based approach. NEUROLOGY 80 4: 353-358. 2013
• Tolppanen Anna-Maija, Kettunen Raimo, Ahonen Riitta, Soininen Hilkka, Hartikainen Sirpa. 2013. Incident ischaemic heart disease in persons with Alzheimer's disease in a Finnish nationwide exposure-matched cohort. INTERNATIONAL JOURNAL OF CARDIOLOGY 170: 195-201. 2013
• Tolppanen AM, Sayers A, Granell R, Fraser WD, Henderson J, Lawlor DA. 2013. Prospective association of 25-hydroxyvitamin d3 and d2 with childhood lung function, asthma, wheezing, and flexural dermatitis. EPIDEMIOLOGY 24 2: 310-319. 2013
• Tolppanen A-M, Lavikainen P, Soininen H, Hartikainen S. 2013. Incident Hip Fractures among Community Dwelling Persons with Alzheimer's Disease in a Finnish Nationwide Register-Based Cohort. PLOS ONE [ONLINE] 8 3: e59124. 2013
• Tolppanen Anna-Maija, Sayers Adrian, Fraser William D, Lewis Glyn, Zammit Stanley, McGrath John, Lawlor Debbie A.. 2012. Serum 25-hydroxyvitamin d(3) and d(2) and non-clinical psychotic experiences in childhood. PLOS ONE [ONLINE] 7 7: e41575. 2012
• Tolppanen Anna-Maija, Sayers Adrian, Fraser William D, Lawlor Debbie A.. 2012. Association of serum 25-hydroxyvitamin D3 and D2 with academic performance in childhood: findings from a prospective birth cohort.. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH Epub ahead of print: Epub ahead of print. 2012
• Tolppanen Anna-Maija, Sayers A, Fraser Wiliam D, Lewis Glyn, Zammit Stan, Lawlor Debbie A. 2012. The association of 25-hydroxyvitamin d(3) and d(2) with behavioural problems in childhood. PLOS ONE [ONLINE] 7 7: e41575. 2012
• Tolppanen Anna-Maija, Sayers Adrian, Fraser Wiliam D, Lewis Glyn, Zammit Stan, Lawlor Debbie A. 2012. The association of serum 25-hydroxyvitamin D3 and D2 with depressive symptoms in childhood - a prospective cohort study. Journal of Child Psychology and Psychiatry 53 7: 757-766. 2012
• Tolppanen Anna-Maija, Fraser Abigail, Fraser Wiliam D, Lawlor Debbie A. 2012. Risk Factors for Variation in 25-Hydroxyvitamin D3 and D2 Concentrations and Vitamin D Deficiency in Children. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 97 4: 1202-1210. 2012
• Tolppanen AM, Solomon A, Soininen H, Kivipelto M. 2012. Midlife Vascular Risk Factors and Alzheimer's Disease: Evidence from Epidemiological Studies. Journal of Alzheimer's Disease 32 3: 531-40. 2012
• Tolppanen AM, Williams D, Henderson J, Lawlor DA. 2011. Serum 25-hydroxy-vitamin D and ionised calcium in relation to lung function and allergen skin tests. EUROPEAN JOURNAL OF CLINICAL NUTRITION 65 4: 493-500. 2011
• Tolppanen AM, Williams D, Lawlor DA. 2011. The association of circulating 25-hydroxyvitamin D and calcium with cognitive performance in adolescents: cross-sectional study using data from the third National Health and Nutrition Examination Survey. PAEDIATRIC AND PERINATAL EPIDEMIOLOGY [HTTP://WWW.BLACKWELL-SCIENCE.COM/~CGILIB/JNLPAGE.ASP?JOURNAL=PPE] 25 1: 67-74. 2011
• Tolppanen AM, Williams DM, Lawlor DA. 2011. The association of serum ionized calcium and vitamin D with adult cognitive performance EPIDEMIOLOGY 22 1: 113-117. 2011